Notes
 | This article about an organization in the United States is a stub. You can help Wikipedia by expanding it. |
CancerQuest is a non-profit education program based at Emory University. The central focus of the program is the CancerQuest website (www.cancerquest.org), which contains information about the biology and treatment of cancer. The development of CancerQuest began in 1998 by Dr. Gregg Orloff in response to his wife's experience with breast cancer. Dr. Orloff is an Assistant Professor of Hematology and Medical Oncology at Emory University. [1]
The CancerQuest website is structured like a textbook. Resources on the site include interviews with patients and cancer researchers at the Winship Cancer Institute of Emory University, 3D animations, and links to scientific articles on PubMed. Content includes normal cell biology, cancer biology, cancer treatments and quality of life issues for cancer patients and their caregivers.
CancerQuest went live in 2002. In 2003 Scientific American listed the site as one of the top five in the category of Medicine. [2] In 2007, CancerQuest was the recipient of the 'Mention of Honour' Award from the European School of Oncology as the best cancer education site located outside of Europe. [3]
Through partnerships with St. Petersburg State University, Russia, University of Siena, Italy, Peking University, China, China Medical University, Taiwan and volunteers in the U.S. the website is available in English, Russian, Italian, Chinese and Spanish.
| This article about an organization in the United States is a stub. You can help Wikipedia by expanding it. |
A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors. In some countries, radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist". Radiation oncologists work closely with other physicians such as surgical oncologists, interventional radiologists, internal medicine subspecialists, and medical oncologists, as well as medical physicists and technicians as part of the multi-disciplinary cancer team. Radiation oncologists undergo four years of oncology-specific training whereas oncologists who deliver chemotherapy have two years of additional training in cancer care during fellowship after internal medicine residency in the United States.
Tianjin Medical University (TMU) was founded in 1951; was the first medical institution approved by the State Council of the People's Republic of China. Hsien-I Chu, a renowned endocrinologist, was the first president of the university. The current president is Shang Yongfeng.
M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri, in 2001 for his contributions in the cancer care field.
The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.
Barrie Joyce Rabinowitz Cassileth was an American medical sociologist and researcher of complementary medicine and a critic of alternative medicine. She published extensively on alternative cancer treatments.
Kunming Medical University, previously known as Kunming Medical College, is a medical school located in Kunming City, Yunnan Province, China.
Dennis Joseph Slamon, is an American oncologist and chief of the division of Hematology-Oncology at UCLA. He is best known for his work identifying the HER2/neu oncogene that is amplified in 25-33% of breast cancer patients and the resulting treatment trastuzumab.
Harbin Medical University (HMU) (Chinese: 哈尔滨医科大学) is a public university located in Harbin, Heilongjiang, China.
Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the Medical Director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
Ketayun Ardeshir Dinshaw FRCR was a prominent personality in the field of Indian medicine and played a significant role in the evolution of modern cancer care in India, and the development of effective radiation therapy. In 2001, the President of India conferred on her the Padma Shri. A prominent news channel has described her as: “The ultimate hope and the last possible post to cling onto for the cancer-struck in India”. Over a thirty-year period, Dinshaw revolutionised cancer medicine in India, refining multi-modal treatments as the exception rather than the rule.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.
Stephan Tanneberger was a German oncologist and chemist who held leading positions in cancer research and therapy in the German Democratic Republic (GDR), serving as director of the Zentralinstitut für Krebsforschung of the Akademie der Wissenschaften der DDR from 1974 until 1990. He left Germany in 1991 to work in the field of palliative care for cancer patients in Italy as well as in various countries in the Third World. In 2005, he founded a Center for Peace Work in Anklam in northeast Germany.
Professor Minesh P. Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.
Cora Sternberg is an American medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital, serving as a member of the Genitourinary (GU) Oncology Program. Dr. Sternberg facilitates the continued growth and development of clinical and translational research programs in GU malignancies, with a particular emphasis on expanding the overall research portfolio. As Clinical Director of the Englander Institute for Precision Medicine (EIPM), Dr. Sternberg will develop strategies to incorporate genomic sequencing and precision medicine throughout the Weill Cornell Medicine and NewYork-Presbyterian healthcare network, including Lower Manhattan, Brooklyn and Queens.
David Henry Gorski is an American surgical oncologist, professor of surgery at Wayne State University School of Medicine, and a surgical oncologist at the Barbara Ann Karmanos Cancer Institute, specializing in breast cancer surgery. He is an outspoken skeptic, and a critic of alternative medicine and the anti-vaccination movement. He is the author of the blog Respectful Insolence, and the managing editor of the website Science-Based Medicine.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Deborah Watkins Bruner is an American researcher, clinical trialist, and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes, symptom management across cancer sites, sexuality after cancer treatment, and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998, with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012, according to the Blue Ridge Institute for Medical Research.
Nabil F. Saba is an American oncologist. He is currently Professor and Vice-chair of Hematology and Medical Oncology, and Professor of Otolaryngology at the Winship Cancer Institute at the Emory University School of Medicine in Atlanta, Georgia. He is a specialist in the field of head and neck oncology. Saba has authored more than 200 peer-reviewed articles. He is the inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research.
W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville, Tennessee.